Our goal is to provide the highest level of expertise and to treat every patient with the same intensity and care we ...

Molecular and genetic testing has become a game-changer in brain tumour care — shaping diagnosis, guiding treatments and opening doors to new therapies. Once available to a handful of patients, these ...

A French start-up has secured €27 million ($29 million) in funding to develop a groundbreaking neurosurgical microrobot. The company, Robeauté, is working on a rice-sized device capable of precisely ...